Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 14 |
GO:0110165 | cellular anatomical entity | 1 | 14 |
GO:0012505 | endomembrane system | 2 | 1 |
GO:0031201 | SNARE complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0098796 | membrane protein complex | 2 | 1 |
Related structures:
AlphaFold database: E9ARV3
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 1 |
GO:0006886 | intracellular protein transport | 4 | 1 |
GO:0006906 | vesicle fusion | 6 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0008104 | protein localization | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0015031 | protein transport | 4 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0016050 | vesicle organization | 5 | 1 |
GO:0022406 | membrane docking | 2 | 1 |
GO:0033036 | macromolecule localization | 2 | 1 |
GO:0045184 | establishment of protein localization | 3 | 1 |
GO:0046907 | intracellular transport | 3 | 1 |
GO:0048278 | vesicle docking | 4 | 1 |
GO:0048284 | organelle fusion | 5 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
GO:0051640 | organelle localization | 2 | 1 |
GO:0051641 | cellular localization | 2 | 1 |
GO:0051649 | establishment of localization in cell | 3 | 1 |
GO:0061024 | membrane organization | 4 | 1 |
GO:0061025 | membrane fusion | 5 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 1 |
GO:0071702 | organic substance transport | 4 | 1 |
GO:0071705 | nitrogen compound transport | 4 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0090174 | organelle membrane fusion | 6 | 1 |
GO:0140056 | organelle localization by membrane tethering | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000149 | SNARE binding | 3 | 1 |
GO:0005484 | SNAP receptor activity | 3 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0030674 | protein-macromolecule adaptor activity | 2 | 1 |
GO:0060090 | molecular adaptor activity | 1 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 202 | 206 | PF00656 | 0.718 |
CLV_NRD_NRD_1 | 109 | 111 | PF00675 | 0.407 |
CLV_NRD_NRD_1 | 135 | 137 | PF00675 | 0.434 |
CLV_NRD_NRD_1 | 174 | 176 | PF00675 | 0.379 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.482 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.367 |
CLV_NRD_NRD_1 | 284 | 286 | PF00675 | 0.380 |
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.341 |
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 135 | 137 | PF00082 | 0.402 |
CLV_PCSK_KEX2_1 | 174 | 176 | PF00082 | 0.505 |
CLV_PCSK_KEX2_1 | 186 | 188 | PF00082 | 0.496 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.354 |
CLV_PCSK_KEX2_1 | 284 | 286 | PF00082 | 0.380 |
CLV_PCSK_PC7_1 | 16 | 22 | PF00082 | 0.359 |
CLV_PCSK_PC7_1 | 280 | 286 | PF00082 | 0.406 |
CLV_PCSK_SKI1_1 | 110 | 114 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 284 | 288 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 54 | 58 | PF00082 | 0.342 |
DEG_APCC_DBOX_1 | 178 | 186 | PF00400 | 0.654 |
DEG_APCC_DBOX_1 | 86 | 94 | PF00400 | 0.632 |
DOC_MAPK_gen_1 | 116 | 127 | PF00069 | 0.592 |
DOC_MAPK_MEF2A_6 | 246 | 254 | PF00069 | 0.557 |
DOC_USP7_MATH_1 | 112 | 116 | PF00917 | 0.614 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.646 |
DOC_USP7_UBL2_3 | 113 | 117 | PF12436 | 0.594 |
DOC_USP7_UBL2_3 | 220 | 224 | PF12436 | 0.625 |
DOC_USP7_UBL2_3 | 274 | 278 | PF12436 | 0.573 |
DOC_USP7_UBL2_3 | 287 | 291 | PF12436 | 0.660 |
LIG_14-3-3_CanoR_1 | 12 | 16 | PF00244 | 0.571 |
LIG_14-3-3_CanoR_1 | 135 | 143 | PF00244 | 0.651 |
LIG_14-3-3_CanoR_1 | 38 | 45 | PF00244 | 0.490 |
LIG_Actin_WH2_2 | 275 | 293 | PF00022 | 0.584 |
LIG_AP2alpha_2 | 43 | 45 | PF02296 | 0.574 |
LIG_CaM_IQ_9 | 167 | 183 | PF13499 | 0.696 |
LIG_EH1_1 | 305 | 313 | PF00400 | 0.395 |
LIG_FHA_1 | 5 | 11 | PF00498 | 0.664 |
LIG_FHA_2 | 12 | 18 | PF00498 | 0.560 |
LIG_FHA_2 | 164 | 170 | PF00498 | 0.717 |
LIG_FHA_2 | 261 | 267 | PF00498 | 0.615 |
LIG_FHA_2 | 38 | 44 | PF00498 | 0.526 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.549 |
LIG_LIR_Gen_1 | 43 | 53 | PF02991 | 0.629 |
LIG_LIR_Nem_3 | 43 | 48 | PF02991 | 0.605 |
LIG_LRP6_Inhibitor_1 | 81 | 87 | PF00058 | 0.371 |
LIG_PCNA_yPIPBox_3 | 278 | 290 | PF02747 | 0.557 |
LIG_Pex14_2 | 315 | 319 | PF04695 | 0.464 |
LIG_SH2_GRB2like | 139 | 142 | PF00017 | 0.599 |
LIG_SH2_STAP1 | 139 | 143 | PF00017 | 0.601 |
LIG_SH2_STAT5 | 3 | 6 | PF00017 | 0.602 |
LIG_SH2_STAT5 | 301 | 304 | PF00017 | 0.370 |
LIG_SUMO_SIM_anti_2 | 200 | 205 | PF11976 | 0.721 |
LIG_TRAF2_1 | 166 | 169 | PF00917 | 0.735 |
LIG_TRAF2_1 | 96 | 99 | PF00917 | 0.648 |
LIG_UBA3_1 | 182 | 188 | PF00899 | 0.719 |
MOD_CK2_1 | 163 | 169 | PF00069 | 0.709 |
MOD_CK2_1 | 93 | 99 | PF00069 | 0.557 |
MOD_Cter_Amidation | 172 | 175 | PF01082 | 0.422 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.437 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.472 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.583 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.574 |
MOD_NEK2_1 | 260 | 265 | PF00069 | 0.484 |
MOD_NEK2_1 | 290 | 295 | PF00069 | 0.655 |
MOD_PIKK_1 | 134 | 140 | PF00454 | 0.583 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.566 |
MOD_PKA_2 | 134 | 140 | PF00069 | 0.606 |
MOD_PKA_2 | 37 | 43 | PF00069 | 0.544 |
MOD_Plk_1 | 204 | 210 | PF00069 | 0.657 |
MOD_Plk_1 | 93 | 99 | PF00069 | 0.587 |
MOD_Plk_2-3 | 163 | 169 | PF00069 | 0.726 |
MOD_Plk_4 | 260 | 266 | PF00069 | 0.565 |
MOD_SUMO_for_1 | 31 | 34 | PF00179 | 0.713 |
TRG_DiLeu_BaEn_1 | 99 | 104 | PF01217 | 0.625 |
TRG_ER_diArg_1 | 109 | 111 | PF00400 | 0.584 |
TRG_ER_diArg_1 | 185 | 187 | PF00400 | 0.668 |
TRG_ER_diArg_1 | 19 | 21 | PF00400 | 0.558 |
TRG_ER_diArg_1 | 284 | 286 | PF00400 | 0.580 |
TRG_NES_CRM1_1 | 95 | 108 | PF08389 | 0.557 |
TRG_NLS_MonoCore_2 | 115 | 120 | PF00514 | 0.640 |
TRG_NLS_MonoExtC_3 | 115 | 120 | PF00514 | 0.605 |
TRG_NLS_MonoExtN_4 | 113 | 120 | PF00514 | 0.607 |
TRG_Pf-PMV_PEXEL_1 | 109 | 114 | PF00026 | 0.431 |
TRG_Pf-PMV_PEXEL_1 | 288 | 292 | PF00026 | 0.429 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1P9J7 | Leptomonas seymouri | 71% | 100% |
A0A0S4IV64 | Bodo saltans | 44% | 94% |
A0A0S4IVZ4 | Bodo saltans | 36% | 97% |
A0A0S4IZ68 | Bodo saltans | 45% | 98% |
A0A1X0P6H2 | Trypanosomatidae | 59% | 100% |
A0A3R7LL06 | Trypanosoma rangeli | 52% | 100% |
A0A3S7WV65 | Leishmania donovani | 93% | 100% |
A4H9V8 | Leishmania braziliensis | 79% | 100% |
A4HY40 | Leishmania infantum | 94% | 100% |
D0A0C4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
Q4QDM0 | Leishmania major | 88% | 100% |
V5BS89 | Trypanosoma cruzi | 55% | 100% |